Mucosal Fixed Drug Eruption with Oral, Conjunctival, Nasal, and Anal Lesions: A Case Report

Authors

  • Noriko Yoshida Department of Dermatology, Nara Medical University School of Medicine, 840 Shijo, Kashihara, Nara 634-8522, Japan
  • Fumi Miyagawa Department of Dermatology, Nara Medical University School of Medicine, 840 Shijo, Kashihara, Nara 634-8522, Japan
  • Yasuhiro Mitsui Department of Dermatology, Nara Medical University School of Medicine, 840 Shijo, Kashihara, Nara 634-8522, Japan
  • Kohei Ogawa Department of Dermatology, Nara Medical University School of Medicine, 840 Shijo, Kashihara, Nara 634-8522, Japan
  • Takashi Hashimoto Department of Dermatology, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno, Osaka 545-8585, Japan
  • Hideo Asada Department of Dermatology, Nara Medical University School of Medicine, 840 Shijo, Kashihara, Nara 634-8522, Japan

DOI:

https://doi.org/10.2340/actadv.v103.18295

Keywords:

mucosal fixed drug eruption, multiple lesions, ofloxacin

Abstract

Abstract is missing (Short communication)

Downloads

Download data is not yet available.

References

Ozkaya E. Oral mucosal fixed drug eruption: characteristics and differential diagnosis. J Am Acad Dermatol 2013; 69: e51-58.

https://doi.org/10.1016/j.jaad.2012.08.019 DOI: https://doi.org/10.1016/j.jaad.2012.08.019

Mizukawa Y, Shiohara T. Fixed drug eruption: a prototypic disorder mediated by effector memory T cells. Curr Allergy Asthma Rep 2009; 9: 71-77.

https://doi.org/10.1007/s11882-009-0011-8 DOI: https://doi.org/10.1007/s11882-009-0011-8

Browne SG. Fixed eruption in deeply pigmented subjects: clinical observations on 350 patients. Br Med J 1964; 2: 1041-1044.

https://doi.org/10.1136/bmj.2.5416.1041 DOI: https://doi.org/10.1136/bmj.2.5416.1041

Mahboob A, Haroon TS. Drugs causing fixed eruptions: a study of 450 cases. Int J Dermatol 1998; 37: 833-838.

https://doi.org/10.1046/j.1365-4362.1998.00451.x DOI: https://doi.org/10.1046/j.1365-4362.1998.00451.x

Marya CM, Sharma G, Parashar VP, Dahiya V. Mucosal fixed drug eruption in a patient treated with ornidazole. J Dermatol Case Rep 2012; 6: 21-24.

https://doi.org/10.3315/jdcr.2012.1091 DOI: https://doi.org/10.3315/jdcr.2012.1091

Park GT, Quan G, Lee JB. Sera from patients with toxic epidermal necrolysis contain autoantibodies to periplakin. Br J Dermatol 2006; 155: 337-343.

https://doi.org/10.1111/j.1365-2133.2006.07323.x DOI: https://doi.org/10.1111/j.1365-2133.2006.07323.x

Cozzani E, Di Zenzo G, Calabresi V, Caproni M, Schena D, Quaglino P, et al. Anti-desmoplakin antibodies in erythema multiforme and Stevens-Johnson syndrome sera: pathogenic or epiphenomenon? Eur J Dermatol 2011; 21: 32-36.

https://doi.org/10.1684/ejd.2010.1150 DOI: https://doi.org/10.1684/ejd.2010.1150

Downloads

Published

2023-12-05

How to Cite

Yoshida, N., Miyagawa, F., Mitsui, Y., Ogawa, K., Hashimoto, T., & Asada, H. (2023). Mucosal Fixed Drug Eruption with Oral, Conjunctival, Nasal, and Anal Lesions: A Case Report. Acta Dermato-Venereologica, 103, adv18295. https://doi.org/10.2340/actadv.v103.18295

Issue

Vol. 103 (2023)

Section

Short Communication

Categories

License

Copyright (c) 2023 Noriko Yoshida, Fumi Miyagawa, Yasuhiro Mitsui, Kohei Ogawa, Takashi Hashimoto, Hideo Asada

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.

Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.

Crossref
Scopus
Google Scholar
Europe PMC